Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5747)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2013 (publication date) through Oct 19, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Prantera C, Scribano ML. Rifaximin and Crohn’s disease. World J Gastroenterol 2013; 19(42): 7487-7488 [PMID: 24259983 DOI: 10.3748/wjg.v19.i42.7487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i42/7487.htm |
| Number | Citing Articles |
| 1 |
L. Boll, W. V. Kern, S. Schuster, M. Schultheiß, C. Schneider, M. Vavra, R. Thimme, S. Rieg, J. Camp, Daniel A. Ortiz.
Frequent high-level rifaximin resistance in
Escherichia coli
associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled study
. Microbiology Spectrum 2025; doi: 10.1128/spectrum.03347-24
|